Stryker Management

Management criteria checks 3/4

Stryker's CEO is Kevin Lobo, appointed in Oct 2012, has a tenure of 11.92 years. total yearly compensation is $20.77M, comprised of 6.7% salary and 93.3% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth R$197.01M. The average tenure of the management team and the board of directors is 6 years and 6.3 years respectively.

Key information

Kevin Lobo

Chief executive officer

US$20.8m

Total compensation

CEO salary percentage	6.7%
CEO tenure	11.9yrs
CEO ownership	0.03%
Management average tenure	6yrs
Board average tenure	6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kevin Lobo's remuneration changed compared to Stryker's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

Compensation vs Market: Kevin's total compensation ($USD20.77M) is above average for companies of similar size in the BR market ($USD5.68M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.

CEO

Kevin Lobo (59 yo)

11.9yrs

Tenure

US$20,767,847

Compensation

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Kevin Lobo	Chairman	11.9yrs	US$20.77m	0.026% $ 197.0m
Glenn Boehnlein	VP & CFO	8.4yrs	US$6.84m	0.0012% $ 8.7m
Viju Menon	Group President of Global Quality & Operations	6.4yrs	US$4.47m	0.0024% $ 18.1m
J. Pierce	Group President of MedSurg & Neurotechnology	6.1yrs	US$6.49m	0.015% $ 112.7m
Spencer Stiles	Group President of Orthopaedics & Spine	6.1yrs	US$6.49m	0.014% $ 102.1m
William Berry	VP & Chief Accounting Officer	3.1yrs	no data	0.00078% $ 5.8m
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	no data	no data
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	6yrs	no data	no data
Jason Beach	Vice President of Finance & Investor Relations	2.2yrs	no data	no data
Robert Fletcher	VP & Chief Legal Officer	5.4yrs	US$2.24m	0.0024% $ 18.3m
Dana McMahon	VP & Chief Compliance Officer	no data	no data	no data
Yin Becker	VP of Communications	5.8yrs	no data	0.0082% $ 61.3m

6.0yrs

Average Tenure

57yo

Average Age

Experienced Management: S1YK34's management team is seasoned and experienced (6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Kevin Lobo	Chairman	11.9yrs	US$20.77m	0.026% $ 197.0m
Lisa Skeete Tatum	Independent Director	4.3yrs	US$319.25k	0.00085% $ 6.3m
Howard Cox	Director Emeritus	6.3yrs	US$38.86k	no data
John Brown	Chairman Emeritus	no data	US$286.99k	5.26% $ 39.3b
Ronda Stryker	Independent Director	40.7yrs	US$319.25k	4.83% $ 36.0b
Mary Brainerd	Independent Director	7.1yrs	US$334.25k	0.0015% $ 11.4m
Allan Golston	Independent Director	13.7yrs	US$334.25k	0.0039% $ 29.2m
Sherilyn S. McCoy	Lead Independent Director	6.3yrs	US$359.25k	0.00022% $ 1.6m
Rajeev Suri	Independent Director	6.3yrs	US$319.25k	0.0014% $ 10.2m
Giovanni Caforio	Independent Director	3.8yrs	US$319.25k	0.00067% $ 5.0m
Andrew Silvernail	Independent Director	10.8yrs	US$339.25k	0.0015% $ 10.9m
Rachel Ruggeri	Independent Director	less than a year	no data	0.000010% $ 74.6k

6.3yrs

Average Tenure

59yo

Average Age

Experienced Board: S1YK34's board of directors are considered experienced (6.3 years average tenure).

Stryker Management

Management criteria checks 3/4

Key information

Recent management updates

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Announces Board Changes

Stryker Corporation Announces Retirement of Roch Doliveux as Board of Directors

Stryker Corporation Appoints Giovanni Caforio as Director

Recent updates

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker Announces Launch of Pangea Plating System

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Stryker to Showcase Q Guidance System with Spine Guidance Software

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

Stryker’s Q Guidance System for Cranial Applications Receives FDA Clearance

Stryker Declares Quarterly Dividend, Payable on April 28, 2023

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q4, 2022 Results on Jan 31, 2023

Stryker Launches Citrefix™ Suture Anchor System

Stryker Corporation Declares Quarterly Dividend, Payable January 31, 2023

Stryker Opens the OR of the Future for Customers to Experience Tomorrow's OR

Stryker Corporation Provides Earnings Guidance for the Year 2022

Stryker Corporation Launches Monterey AI Interbody System with New Pre-Clinical Data

Stryker Launches Q Guidance System with Spine Guidance Software

Stryker Receives FDA Clearance for OptaBlate Bone Tumor Ablation System

Stryker Launches Pulse Intelligent Delivery Platform

Stryker Launches New Gamma4 Hip Fracture Nailing System

Stryker Declares Quarterly Dividend, Payable on October 31, 2022

Stryker Corporation Provides Earnings Guidance for the Full Year of 2022

Stryker Corporation to Report Q2, 2022 Results on Jul 26, 2022

Lieff Cabraser & Shavitz Law Group Files Federal Collective and California Class Action Lawsuit Against Stryker Corporation for Failure to Pay Overtime Wages, Provide Meal and Rest Breaks, and Pay Business Expenses

Stryker Receives FDA Clearance for Q Guidance System for Spine Applications

Stryker Corporation Announces Board Changes

Stryker Corporation Declares Quarterly Dividend, Payable July 29, 2022

Stryker Corporation to Report Q1, 2022 Results on Apr 28, 2022

Stryker Launches PROstep™ MICA® SOLO Guide

Stryker Corporation (NYSE:SYK) completed the acquisition of Vocera Communications, Inc. (NYSE:VCRA).

Stryker Declares Quarterly Dividend, Payable April 29, 2022

Stryker Announces New Tornier Perform® Patient-Matched Primary Reversed Glenoid

Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire Vocera Communications, Inc. (NYSE:VCRA) for $2.9 billion.

Stryker Corporation (NYSE:SYK) acquired Gauss Surgical, Inc.

Stryker Launches T2 Alpha Femur Retrograde Nailing System

Stryker Launches SurgiCount+ Safety-Sponge System

Stryker Introduces Tornier Shoulder Arthroplasty Portfolio and Launches New Tornier Perform Humeral System

Stryker Declares Quarterly Dividend Payable on July 30, 2021

Stryker Corporation Provides Earnings Guidance for the Year of 2021

Critical Care Diagnostics, Inc. acquired T/Pump Product Line from Stryker Corporation (NYSE:SYK).

Stryker Corporation Announces Retirement of Roch Doliveux as Board of Directors

Stryker Corporation Launches Hospital Bed

Stryker Corporation Announces Not to Provide Quarterly Guidance

Stryker Corporation (NYSE:SYK) acquired OrthoSensor, Inc.

Stryker Launches T7™ Personal Protection System

DJO Global, Inc. completed the acquisition of STAR Total Ankle Replacement, Finger Joint Replacement Products and Related Assets from Stryker Corporation (NYSE:SYK).